Indeed, a possible strategy for treating anthrax infections may be with a cocktail of derivatives of both sets of molecules, blocking the PA/CMG2 interaction via both the human receptor, and the bacterial protein. This evidence concerns the gene ANTXR2 and anthrax infection.